Brookfield Asset Management - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
Brookfield Asset Management ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$1,458,127
+17.8%
150,633
+50.6%
0.01%
+20.0%
Q1 2022$1,238,000
-82.5%
100,000
-67.7%
0.01%
-81.5%
Q4 2021$7,090,000
+560.1%
310,000
+538.9%
0.03%
+575.0%
Q3 2021$1,074,000
+75.2%
48,518
+2.6%
0.00%
+33.3%
Q2 2021$613,00047,3070.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 503,248$6,535,00010.30%
Prosight Management, LP 360,834$4,685,0003.84%
Healthcare Value Capital, LLC 100,000$1,299,0002.89%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,748,208$22,700,0002.32%
DG Capital Management, LLC 591,154$7,676,0001.83%
NEA Management Company, LLC 5,172,683$67,193,0001.51%
Altium Capital Management LP 408,908$5,310,0001.47%
IRONWOOD INVESTMENT MANAGEMENT LLC 170,316$2,212,0001.17%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 298,500$3,875,0001.02%
KNOTT DAVID M 154,840$2,011,0000.86%
View complete list of AURINIA PHARMACEUTICALS INC shareholders